Ming-Rui Li
Research Subjects
Research Interests
Ming-Rui Li has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Jing Li
Institute of Clinical Pharmacology, School of Medicine, Zhengzhou University, Zhengzhou, 450052, People's Republic of China
2 shared publications- Jun Peng
Xiangya School of Pharmaceutical Sciences, Department of Pharmacology, Central South University, Changsha 410083, China
2 shared publications Bao Sun
Institute of Clinical Pharmacology, School of Medicine, Zhengzhou University, Zhengzhou, 450052, People's Republic of China
1 shared publication- Bing Qi
Drug Delivery and Disposition, KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium
1 shared publication Cheng-Ming Liu
Institute of Clinical Pharmacology, School of Medicine, Zhengzhou University, Zhengzhou, 450052, People's Republic of China
1 shared publicationGao-Ju Wang
Institute of Clinical Pharmacology, School of medicine, Zhengzhou University, Zhengzhou 450052, Chin
1 shared publication
Latest Publications
- 31 July 2024
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 400, 111179
Micafungin protects mouse heart against doxorubicin-induced oxidative injury via suppressing MALT1-dependent k48-linked ubiquitination of Nrf2
- 31 July 2024
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 400, 111179
Micafungin protects mouse heart against doxorubicin-induced oxidative injury via suppressing MALT1-dependent k48-linked ubiquitination of Nrf2
- Open Access
- 7 September 2023
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 79 (4) , 719-730
Role of sonic hedgehog signaling pathway in the regulation of ion channels: focus on its association with cardio-cerebrovascular diseases
Sonic hedgehog (SHH) signaling is vital for cell differentiation and proliferation during embryonic development, yet its role in cardiac, cerebral, and vascular pathophysiology is under debate. Recent studies have demonstrated that several compounds of SHH signaling regulate ion channels, which in turn affect the behavior of target cells. Some of these ion channels are involved in the cardio-cerebrovascular system. Here, we first reviewed the SHH signaling cascades, then its interaction with ion channels, and their impact on cardio-cerebrovascular diseases. Considering the complex cross talk of SHH signaling with other pathways that also affect ion channels and their potential impact on the cardio-cerebrovascular system, we highlight the necessity of thoroughly studying the effect of SHH signaling on ion homeostasis, which could serve as a novel mechanism for cardio-cerebrovascular diseases. Graphical Abstract Activation of SHH signaling influence ion channels activity, which in turn influence ion homeostasis, membrane potential, and electrophysiology, could serve as a novel strategy for cardio-cerebrovascular diseases
- 7 September 2023
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 79 (4) , 719-730
Open AccessRole of sonic hedgehog signaling pathway in the regulation of ion channels: focus on its association with cardio-cerebrovascular diseases
Sonic hedgehog (SHH) signaling is vital for cell differentiation and proliferation during embryonic development, yet its role in cardiac, cerebral, and vascular pathophysiology is under debate. Recent studies have demonstrated that several compounds of SHH signaling regulate ion channels, which in turn affect the behavior of target cells. Some of these ion channels are involved in the cardio-cerebrovascular system. Here, we first reviewed the SHH signaling cascades, then its interaction with ion channels, and their impact on cardio-cerebrovascular diseases. Considering the complex cross talk of SHH signaling with other pathways that also affect ion channels and their potential impact on the cardio-cerebrovascular system, we highlight the necessity of thoroughly studying the effect of SHH signaling on ion homeostasis, which could serve as a novel mechanism for cardio-cerebrovascular diseases. Graphical Abstract Activation of SHH signaling influence ion channels activity, which in turn influence ion homeostasis, membrane potential, and electrophysiology, could serve as a novel strategy for cardio-cerebrovascular diseases
- 7 June 2019
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 44 (6) , 787-796
Inhibition of Rat CYP1A2 and CYP2C11 by Honokiol, a Component of Traditional Chinese Medicine
Honokiol, a major constituent isolated from Magnolia officinalis, is regarded as a phytochemical marker and bioactive substance present in many traditional Chinese medicines. However, the effect of honokiol on cytochrome P450 (CYP) has not been thoroughly investigated. The aim of this study was to investigate the effect of honokiol on CYP1A2 and CYP2C11 in vitro and in vivo.
- 7 June 2019
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 44 (6) , 787-796
Inhibition of Rat CYP1A2 and CYP2C11 by Honokiol, a Component of Traditional Chinese Medicine
Honokiol, a major constituent isolated from Magnolia officinalis, is regarded as a phytochemical marker and bioactive substance present in many traditional Chinese medicines. However, the effect of honokiol on cytochrome P450 (CYP) has not been thoroughly investigated. The aim of this study was to investigate the effect of honokiol on CYP1A2 and CYP2C11 in vitro and in vivo.
- Open Access
- 1 December 2018
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 367 (3) , 473-482
Higher Activity of Alcohol Dehydrogenase Is Correlated with Hepatic Fibrogenesis
Hepatofibrosis can progress to cirrhosis and hepatocellular carcinoma (HCC). Prevention, stabilization and reversal disease progression is vital for patients with hepatofibrosis, and identifying risk factors for hepatofibrosis is urgently needed. This study examines the activities of alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH) in the fibrotic livers from HCC patients (n=88) with comparison to the activities found in patients with normal livers (n=74). A fibrosis-carcinoma rat model was used to study activity of ADH in fibrosis and HCC, and relationship between innate ADH activity and extent of hepatofibrosis or HCC. There was substantial inter-individual variation in the activities of ADH and ALDH in normal livers. The activities of total ADH, ADHI and ADHII in fibrotic livers were significantly higher than that in normal liver (P < 0.001), while the activity of ALDH was slightly higher. The positive rates of ADHI and ADHII were 84.1% and 77.3%; the area under the receiver operator characteristics (ROC) curve was 0.943 and 0.912, respectively. For the rat model as compared to the control, ADH activity in liver was significantly increased at the fibrotic and HCC stages and there was no significant difference between ADH activity in liver at these two stages. The innate activity of ADH in serum was well correlated with the extent of hepatofibrosis as indicated by Masson area%, Ki67+%, PCNA+%, and GST-p average density at fibrotic stage but not at HCC stage. Higher activity of ADH is a risk factor for hepatofibrogenesis and it might be a prevention target for hepatofibrosis.
- 1 December 2018
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 367 (3) , 473-482
Open AccessHigher Activity of Alcohol Dehydrogenase Is Correlated with Hepatic Fibrogenesis
Hepatofibrosis can progress to cirrhosis and hepatocellular carcinoma (HCC). Prevention, stabilization and reversal disease progression is vital for patients with hepatofibrosis, and identifying risk factors for hepatofibrosis is urgently needed. This study examines the activities of alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH) in the fibrotic livers from HCC patients (n=88) with comparison to the activities found in patients with normal livers (n=74). A fibrosis-carcinoma rat model was used to study activity of ADH in fibrosis and HCC, and relationship between innate ADH activity and extent of hepatofibrosis or HCC. There was substantial inter-individual variation in the activities of ADH and ALDH in normal livers. The activities of total ADH, ADHI and ADHII in fibrotic livers were significantly higher than that in normal liver (P < 0.001), while the activity of ALDH was slightly higher. The positive rates of ADHI and ADHII were 84.1% and 77.3%; the area under the receiver operator characteristics (ROC) curve was 0.943 and 0.912, respectively. For the rat model as compared to the control, ADH activity in liver was significantly increased at the fibrotic and HCC stages and there was no significant difference between ADH activity in liver at these two stages. The innate activity of ADH in serum was well correlated with the extent of hepatofibrosis as indicated by Masson area%, Ki67+%, PCNA+%, and GST-p average density at fibrotic stage but not at HCC stage. Higher activity of ADH is a risk factor for hepatofibrogenesis and it might be a prevention target for hepatofibrosis.